Page last updated: 2024-11-07

kca 098

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

KCA 098: an inhibitor of bone resorption; has no estrogenic activity; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131124
SCHEMBL ID9781425
MeSH IDM0233425

Synonyms (13)

Synonym
3,9-bis(n,n-dimethylcarbamoyloxy)-5h-benzofuro(3,2-c)quinoline-6-one
carbamic acid, dimethyl-, 5,6-dihydro-6-oxobenzofuro(3,2-c)quinoline-3,9-diyl ester
5,6-dihydro-6-oxobenzofuro(3,2-c)quinoline-3,9-diyl dimethylcarbamate
129794-24-7
kca-098
kca 098
[9-(dimethylcarbamoyloxy)-6-oxo-5h-[1]benzofuro[3,2-c]quinolin-3-yl] n,n-dimethylcarbamate
IHQFYMAOIYJTBA-UHFFFAOYSA-N ,
3,9-bis(n,n-dimethylcarbamoyloxy)-5h-benzofuro[3,2-c]quinolin-6-one
SCHEMBL9781425
DTXSID30156241
6-oxo-5,6-dihydrobenzofuro[3,2-c]quinoline-3,9-diyl bis(dimethylcarbamate)
PD160250
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (80.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]